Try our Advanced Search for more refined results
Life Sciences - March, 2006
56 articles
- Authorized Generics Under Scrutiny By The FTC
- Authorized Generics: Antitrust Issues And The Hatch-Waxman Act
- Drug Industry Faces Vast Antitrust Probe
- Ailing Healthcare Company Gets Shot In The Arm
- In Paxil Fraud Scheme, Glaxo Pays The Price
- Medtronic Suffers Fresh Defeat In Stent Dispute
- Judge Refuses Boston Scientific Bid To Toss Jury Verdict
- Despite Patent Attack, Schering Will Bring Yaz To U.S.
- Class Action Suit Filed Over Stock Price Tampering
- Reed Smith's IP Group: A True Blend
- In Setback For Masimo, Judge Tosses $420M Award
- Curative Health Files Chapter 11 With $255M In Debts
- Plavix Deal Triggers Antitrust Lawsuit
- Brussels Snapshot: Shearman & Sterling
- E.U. Expands Antitrust Review Of Guidant Deal
- Boston Scientific Merger Delayed Over EC Concerns
- Arnold & Porter Tops Antitrust Litigation Survey
- Aventis Presses On With Allegra Crusade
- J&J Unit Loses Out To Medtronic In Stent Case
- Trademark Specialist Fross Zelnick Flies Solo
- Apotex Surrenders In Plavix Patent Saga
- Ivax, Forest Square Off Over Antidepressant Drug
- Drug Stores Allege Ovcon Antitrust Conspiracy
- Supreme Court Hears Much-Watched LabCorp Case
- In Blow To EchoStar, Judge Advances TiVo Case
- In Levaquin Patent Battle, Daiichi Scores Again
- J&J Subsidiary Scores Another Victory In Stent Case
- Brussels Snapshot: Skadden Arps
- St. Jude Caught In SEC's Oil-For-Food Net
- Novartis Takes Aim At Watson Over Lotrel
- USG Seeks To Acquire Paper Mill for $18M
- FDA Forced To Review Cholesterol Drug Exclusivity
- Abbott Bids To Toss Antitrust Charges Over TriCor
- Apotex Launches Pre-Emptive Strike Against Par
- BASF, Daiichi Vitamin Cartel Fines Slashed By E.U. Court
- J&J On Warpath Over Schizophrenia Drug
- Solvay, Akzo Nobel Fined $72M For Chemical Cartels
- Boston Scientific Curiously Withdraws Then Refiles
- Novogen Sues Chattem Over Preventative Health Methods
- Latham & Watkins Scores New Partner
- Allergan, Alcon Settle Patent Feud Over Eye Drops
- Botched Deal Follows AAIPharma's Solvency
- Pfizer Sues Philippines Over Generic Norvasc
- AstraZeneca Starts Patent Squabble With IVAX
- Bill Would Cut Use Of 30-Month Stay In Drug Suits
- Roche Wins First Indian Product Patent
- Federal Circuit Sends Stent Case To Germany
- E.U. Probes Boston Scientific, Abbott Over Guidant Bids
- Conferences Highlight Foley & Lardner's IP Expertise
- Medtronic Pins Infringement Charges on Boston Scientific
- Alza Hit With Class Action Lawsuit Over Ditropan XL
- AstraZeneca Hit Again With Antitrust Charges
- ABB's Asbestos-Related Reorganization Approved
- MedImmune Case: Implications For Licensing Agreements
- Sanofi-Aventis Slaps Ranbaxy With Allegra Patent Suit
- Metrologic Ordered To Pay $13M Arbitration Award